Hypromellose Eye Drops 0.7% For Solution
NDC Package 16030-101-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Hypromellose Eye Drops 0.7% for solutions is lnstill 1or 2 drops in the affected eye, as needed. This formulation utilizes a for solution delivery system. Marketed by Aurolab, this product is identified by NDC 16030-101 and is authorized under FDA application M018.

Identification & Billing

NDC Package Code
16030-101-10
Package Description
10 mL in 1 BOTTLE, DROPPER
Product Code
11-Digit Billing Format
16030010110

Clinical Specifications

Proprietary Name
Hypromellose Eye Drops 0.7%
Non-Proprietary Name
Hypromellose Eye Drops 0.7%
Substance Name
Hypromellose 2910 (4000 Mpa.s)
Dosage Form
For Solution - A product, usually a solid, intended for solution prior to administration.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Usage Information
Lnstill 1or 2 drops in the affected eye, as needed

Regulatory & Marketing

Labeler Name
Aurolab
Product Type
Human Otc Drug
FDA Application #
M018
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
09-01-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 16030-101-10 identifies a specific commercial package of 10 ml in 1 bottle, dropper of Hypromellose Eye Drops 0.7%, a human over the counter drug labeled by Aurolab. This for solution is formulated for topical use and contains hypromellose 2910 (4000 mpa.s) as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Aurolab on September 01, 2022. The current certification is valid through December 31, 2026.

How is this Aurolab product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 16030010110. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
16030-101-10
11-Digit CMS (5-4-2)
16030-0101-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.